1. POINT Trial (Platelet-Oriented Inhibition in New TIA). A randomized, double-blind controlled trial evaluating if clopidogreal is effective in improving survival from major ischemic vascular events at 90 days for new TIAs or minor strokes.
Sponsor: NIH
Faculty: Bruce Lo, M.D., RDMS, FACEP

2. Human Papilloma Virus (HPV) testing in the Emergency Department
Faculty:  Alicia Devine, M.D., FACEP
Residents:  Valerie Baur, M.D., Reina Parker, M.D.
Received a $50,000 grant from Merck to conduct the study.

3. B-RIPPED Ultrasound Study.  The use of ultrasound in evaluating patients presenting with dyspnea, examining for Right ventricle enlargement, IVC collapse, Pericardial effusion, Pleural effusion, PE and DVT.
Faculty: Don Byars, M.D, RDMS, FACEP, Barry Knapp, M.D., RDMS, FACEP, David Evans, M.D.
Residents:  Virginia Stewart, M.D., Valerie Baur, M.D., Brian Campbell, M.D.

4. The Role of a Structured Journal Club on Evidence Based Knowledge Acquisition in Postgraduate Emergency Medicine Education: Multi-Center Study.
Faculty : Charles Graffeo, MD., ABEM-UHM, Chris Carpenter, M.D. (Washington University), and B. Kane, M.D. (Lehigh Valley)

5. MN-221-CL007, A Phase II randomized, double-blind placebo controlled study to evaluate the safety and efficacy of MN-221 when administered intravenously as an adjunct to standard therapy to adults with an exacerbation of asthma.
Sponsor: MediciNova
Faculty:  Francis L. Counselman, M.D., CPE, FACEP